79 related articles for article (PubMed ID: 14965550)
21. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a community-based intervention to enhance breast cancer screening practices in Brazil.
Thuler LC; Freitas HG
J Eval Clin Pract; 2008 Dec; 14(6):1012-7. PubMed ID: 18759754
[TBL] [Abstract][Full Text] [Related]
23. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
24. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
[TBL] [Abstract][Full Text] [Related]
25. Inequalities in breast cancer stage at diagnosis in the Trent region, and implications for the NHS Breast Screening Programme.
Cuthbertson SA; Goyder EC; Poole J
J Public Health (Oxf); 2009 Sep; 31(3):398-405. PubMed ID: 19423544
[TBL] [Abstract][Full Text] [Related]
26. Outcomes among women younger than age 40 in a state breast cancer screening program.
Vetto JT; Wheeler AJ; Toomey M; Schmidt KJ
Am J Surg; 2006 May; 191(5):635-40. PubMed ID: 16647351
[TBL] [Abstract][Full Text] [Related]
27. Interval cancers in the Dutch breast cancer screening programme.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
[TBL] [Abstract][Full Text] [Related]
28. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a surveillance programme for women with a family history of breast cancer.
Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
[TBL] [Abstract][Full Text] [Related]
30. Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Hendriks JH; Verbeek AL; van Ineveld BM; de Bruyn AE; van der Maas PJ
Int J Cancer; 1998 Mar; 75(5):694-8. PubMed ID: 9495236
[TBL] [Abstract][Full Text] [Related]
31. Malpractice claims following screening mammography in The Netherlands.
van Breest Smallenburg V; Setz-Pels W; Groenewoud JH; Voogd AC; Jansen FH; Louwman MW; Tielbeek AV; Duijm LE
Int J Cancer; 2012 Sep; 131(6):1360-6. PubMed ID: 22173962
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands.
Schouten LJ; de Rijke JM; Schlangen JT; Verbeek AL
J Med Screen; 1998; 5(1):37-41. PubMed ID: 9575459
[TBL] [Abstract][Full Text] [Related]
33. Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).
De Koning HJ; Fracheboud J; Boer R; Verbeek AL; Collette HJ; Hendriks JH; van Ineveld BM; de Bruyn AE; van der Maas PJ
Int J Cancer; 1995 Mar; 60(6):777-80. PubMed ID: 7896444
[TBL] [Abstract][Full Text] [Related]
34. Interval cancers following breast cancer screening in Singaporean women.
Gao F; Chia KS; Ng FC; Ng EH; Machin D
Int J Cancer; 2002 Oct; 101(5):475-9. PubMed ID: 12216077
[TBL] [Abstract][Full Text] [Related]
35. Danish Quality Database for Mammography Screening.
Mikkelsen EM; Njor SH; Vejborg I
Clin Epidemiol; 2016; 8():661-666. PubMed ID: 27822113
[TBL] [Abstract][Full Text] [Related]
36. Two more screens per woman would improve effectiveness of UK breast cancer screening.
BMJ; 1998 Aug; 317(7155):C. PubMed ID: 9694786
[No Abstract] [Full Text] [Related]
37. Quality Control of the Hungarian Nationwide Mammography Screening Programme.
Boncz I; Endrei D; Ágoston I; Vajda R; Csákvári T; Kovács G; Sebestyén A
Value Health; 2014 Nov; 17(7):A740. PubMed ID: 27202665
[No Abstract] [Full Text] [Related]
38. Method of primary breast cancer detection and the disease-free interval, adjusting for lead time.
de Munck L; Eijkelboom AH; Otten JDM; Broeders MJM; Siesling S
J Natl Cancer Inst; 2024 Mar; 116(3):370-378. PubMed ID: 37935443
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening.
Tomšič S; Žagar T; Mihor A; Mlakar M; Lokar K; Jarm K; Zadnik V
PLoS One; 2022; 17(11):e0278384. PubMed ID: 36449489
[TBL] [Abstract][Full Text] [Related]
40. Quality assured implementation of the Slovenian breast cancer screening programme.
Jarm K; Kadivec M; Šval C; Hertl K; Primic Žakelj M; Dean PB; von Karsa L; Žgajnar J; Gazić B; Kutnar V; Zdešar U; Kurir Borovčić M; Zadnik V; Josipović I; Krajc M
PLoS One; 2021; 16(10):e0258343. PubMed ID: 34624045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
